Development of a population pharmacokinetic model for Genasense™ and its active metabolites.

被引：0
|
作者：
Gupta, M
Julian, TN
Barrett, JS
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Genta Inc, Berkeley Hts, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.194
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P54 / P54
页数：1
相关论文
共 50 条
  • [31] Development of a pharmacokinetic limited sampling model for temozolomide and its active metabolite MTIC
    Kirstein, MN
    Panetta, JC
    Gajjar, A
    Nair, G
    Iacono, LC
    Freeman, BB
    Stewart, CF
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (05) : 433 - 438
  • [32] PHARMACOKINETIC MODELING OF ETHYL LOFLAZEPATE (VICTAN) AND ITS MAIN ACTIVE METABOLITES
    BA, BB
    ILIADIS, A
    CANO, JP
    [J]. ANNALS OF BIOMEDICAL ENGINEERING, 1989, 17 (06) : 633 - 646
  • [33] Population pharmacokinetic model of irinotecan and its four main metabolites in patients treated with FOLFIRI or FOLFIRINOX regimen
    Deyme, Laure
    Barbolosi, Dominique
    Mbatchi, Litaty Cephanoee
    Tubiana-Mathieu, Nicole
    Ychou, Marc
    Evrard, Alexandre
    Gattacceca, Florence
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (02) : 247 - 258
  • [34] Population pharmacokinetic model of irinotecan and its four main metabolites in patients treated with FOLFIRI or FOLFIRINOX regimen
    Laure Deyme
    Dominique Barbolosi
    Litaty Céphanoée Mbatchi
    Nicole Tubiana-Mathieu
    Marc Ychou
    Alexandre Evrard
    Florence Gattacceca
    [J]. Cancer Chemotherapy and Pharmacology, 2021, 88 : 247 - 258
  • [35] A Population Pharmacokinetic Model for Low-Dose Methotrexate and its Polyglutamated Metabolites in Red Blood Cells
    Julia Korell
    Lisa K. Stamp
    Murray L. Barclay
    Judith M. Dalrymple
    Jill Drake
    Mei Zhang
    Stephen B. Duffull
    [J]. Clinical Pharmacokinetics, 2013, 52 : 475 - 485
  • [36] A Population Pharmacokinetic Model for Low-Dose Methotrexate and its Polyglutamated Metabolites in Red Blood Cells
    Korell, Julia
    Stamp, Lisa K.
    Barclay, Murray L.
    Dalrymple, Judith M.
    Drake, Jill
    Zhang, Mei
    Duffull, Stephen B.
    [J]. CLINICAL PHARMACOKINETICS, 2013, 52 (06) : 475 - 485
  • [37] Development and Application of a Mechanistic Pharmacokinetic Model for Simvastatin and its Active Metabolite Simvastatin Acid Using an Integrated Population PBPK Approach
    Tsamandouras, Nikolaos
    Dickinson, Gemma
    Guo, Yingying
    Hall, Stephen
    Rostami-Hodjegan, Amin
    Galetin, Aleksandra
    Aarons, Leon
    [J]. PHARMACEUTICAL RESEARCH, 2015, 32 (06) : 1864 - 1883
  • [38] Development and Application of a Mechanistic Pharmacokinetic Model for Simvastatin and its Active Metabolite Simvastatin Acid Using an Integrated Population PBPK Approach
    Nikolaos Tsamandouras
    Gemma Dickinson
    Yingying Guo
    Stephen Hall
    Amin Rostami-Hodjegan
    Aleksandra Galetin
    Leon Aarons
    [J]. Pharmaceutical Research, 2015, 32 : 1864 - 1883
  • [39] Ion chromatography for the analysis of glyphosate and its selected metabolites. A review
    Michalski, Rajmund
    Pecyna-Utylska, Paulina
    [J]. JOURNAL OF SEPARATION SCIENCE, 2023, 46 (12)
  • [40] EFFECT OF MODERATE HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF AFICAMTEN AND ITS METABOLITES.
    Xu, D.
    Divanji, P.
    Kim, E.
    Li, J.
    Benattia, Y.
    Griffith, A.
    Kupfer, S.
    German, P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S8 - S9
12345